Surgery and Catheter Ablation for Atrial Fibrillation: History, Current Practice, and Future Directions.
Patrick M McCarthyJames L CoxOlga N KislitsinaJane KruseAndrei ChurylaS Chris MalaisrieChristopher K MehtaPublished in: Journal of clinical medicine (2021)
Atrial fibrillation (AF) is the most common of all cardiac arrhythmias, affecting roughly 1% of the general population in the Western world. The incidence of AF is predicted to double by 2050. Most patients with AF are treated with oral medications and only approximately 4% of AF patients are treated with interventional techniques, including catheter ablation and surgical ablation. The increasing prevalence and the morbidity/mortality associated with AF warrants a more aggressive approach to its treatment. It is the purpose of this invited editorial to describe the past, present, and anticipated future directions of the interventional therapy of AF, and to crystallize the problems that remain.
Keyphrases
- atrial fibrillation
- catheter ablation
- left atrial
- left atrial appendage
- oral anticoagulants
- direct oral anticoagulants
- heart failure
- newly diagnosed
- risk factors
- end stage renal disease
- percutaneous coronary intervention
- mental health
- healthcare
- ejection fraction
- chronic kidney disease
- minimally invasive
- peritoneal dialysis
- cardiovascular events
- stem cells
- cardiovascular disease
- coronary artery bypass
- coronary artery disease
- mesenchymal stem cells
- type diabetes
- acute coronary syndrome
- cell therapy
- patient reported outcomes
- combination therapy
- surgical site infection
- venous thromboembolism
- congenital heart disease